-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Zura Bio, Lowers Price Target to $17

Benzinga·05/09/2025 17:50:19
Listen to the news
Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $19 to $17.